Sign up to save your podcasts
Or
Share Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 2
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 2
Dr Rinath M Jeselsohn and Dr Joyce O’Shaughnessy review current literature and datasets exploring the use of oral selective estrogen receptor degraders for the management of metastatic breast cancer.
CME information and select publications here.
View all episodes
By Dr. Neil Love
4.4
6363 ratings
Dr Rinath M Jeselsohn and Dr Joyce O’Shaughnessy review current literature and datasets exploring the use of oral selective estrogen receptor degraders for the management of metastatic breast cancer.
CME information and select publications here.
More shows like Breast Cancer Update
View all
JAMA Editors' Summary
137 Listeners
NEJM This Week
317 Listeners
JAMA Clinical Reviews
498 Listeners
Lung Cancer Update
31 Listeners
Hematologic Oncology Update
73 Listeners
Prostate Cancer Update
14 Listeners
Gastrointestinal Cancer Update
17 Listeners
Gynecologic Oncology Update
12 Listeners
Dermatologic Oncology Update
0 Listeners
Research To Practice | Oncology Videos
120 Listeners
Breastcancer.org Podcast
44 Listeners
ASCO Daily News
58 Listeners
The Curbsiders Internal Medicine Podcast
3,348 Listeners
Core IM | Internal Medicine Podcast
1,148 Listeners
ASCO Guidelines
45 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
367 Listeners
Oncology Today with Dr Neil Love
57 Listeners
Oncology Nursing Update with Dr Neil Love: Focus on Oncology Nursing
0 Listeners